Featured Archives - Page 14 of 22

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

THIS WEEK'S STORIES

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

June 5, 2025

Scholar Rock Names Rebecca McLeod Chief Brand Officer and U.S. General Manager to Lead Apitegromab Launch

June 2, 2025

NCCN Guidelines Now Recommend FES PET Imaging for Lobular Breast Cancer, Expanding Use of GE HealthCare’s Cerianna

May 30, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

ConcertAI Unveils AI-Powered Precision Suite to Revolutionize Oncology Research and Life Sciences

Most Read

IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders

Charter Next Generation Names Lisa Alteri as Chief Operating Officer to Drive Operational Strategy and Growth

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds

EDITOR PICKS

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

THIS WEEK'S STORIES

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

Scholar Rock Names Rebecca McLeod Chief Brand Officer and U.S. General Manager to Lead Apitegromab Launch

NCCN Guidelines Now Recommend FES PET Imaging for Lobular Breast Cancer, Expanding Use of GE HealthCare’s Cerianna

POPULAR CATEGORY

ABOUT US

FOLLOW US